Latest Insider Transactions at Aziyo Biologics, Inc. (AZYO)
This section provides a real-time view of insider transactions for Aziyo Biologics, Inc. (AZYO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AZIYO BIOLOGICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AZIYO BIOLOGICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2021
|
Ronald K. Lloyd PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
8,565
+15.21%
|
$94,215
$11.97 P/Share
|
|
Oct 13
2020
|
Ronald K. Lloyd PRESIDENT AND CEO |
BUY
Conversion of derivative security
|
Direct |
14,586
+50.0%
|
-
|
|
Oct 13
2020
|
High Cape Capital, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
441,176
+8.91%
|
$7,499,992
$17.0 P/Share
|
|
Oct 13
2020
|
High Cape Capital, L.P. Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
2,451
-0.06%
|
$12,255
$5.44 P/Share
|
|
Oct 13
2020
|
High Cape Capital, L.P. Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
7,655
+0.19%
|
$38,275
$5.44 P/Share
|
|
Oct 13
2020
|
High Cape Capital, L.P. Director |
BUY
Conversion of derivative security
|
Indirect |
4,062,451
+50.0%
|
-
|